Mookherjee S, Henion W, Warner R, Eich R H, Smulyan H, Obeid A I
J Clin Pharmacol. 1978 Jan;18(1):67-75. doi: 10.1002/j.1552-4604.1978.tb01562.x.
Twelve of 17 patients (group A) with congestive cardiomyopathy improved hemodynamically during sodium nitroprusside (NP) infusion. Five patients (group B) failed to increase their cardiac output. The two groups were identical in clinical presentation and had comparable cardiomegaly and left ventricular filling pressure (LVFP). However, group A had a baseline cardiac index (CI) lower than 2.5 L/min/m2 and high peripheral systemic (PSR) and total pulmonary vascular resistance (PR). In contrast, group B had a control of CI of higher than 2.5 L/min/m2 and near normal PSR and PR. Furthermore, a highly significant correlation was observed between the calculated levels of control PSR and their subsequent reduction during NP infusion. The higher the initial resistance, the more marked was its fall on NP as documented in group A. In group B, the PSR was probably not high enough for NP to be effective in increasing the cardiac output further by vasodilatation. We conclude that NP infusion may not increase cardiac output in congestive cardiomyopathy, in spite of a high LVFP, if the PSR is near normal.
17例充血性心肌病患者中的12例(A组)在输注硝普钠(NP)期间血流动力学得到改善。5例患者(B组)的心输出量未能增加。两组临床表现相同,心脏扩大程度和左心室充盈压(LVFP)相当。然而,A组的基线心脏指数(CI)低于2.5L/min/m²,外周体循环阻力(PSR)和总肺血管阻力(PR)较高。相比之下,B组的CI控制值高于2.5L/min/m²,PSR和PR接近正常。此外,观察到计算出的对照PSR水平与其在NP输注期间的随后降低之间存在高度显著的相关性。如A组所示,初始阻力越高,其在NP作用下的下降就越明显。在B组中,PSR可能不够高,以至于NP无法通过血管扩张进一步有效增加心输出量。我们得出结论,如果PSR接近正常,尽管LVFP较高,但在充血性心肌病中输注NP可能不会增加心输出量。